Elis S, Wu Y, Courtland HW, Cannata D, Sun H, Beth-On M, Liu C, Jasper H, Domen H, Karabatas L, Guida C, Basta-Pljakic J, Cardoso L, Rosen CJ, Frystyk J, Yakar S
GLP-1 Market Share, By Indication, 2025 (%) The obesity and weight management segment held a 28% share of the market in 2025 and is expected to grow at the fastest CAGR of 18.6% during the projection period
Nurse Practitioners (NPs): Advanced practice registered nurses who can prescribe medications in many regions, often working in primary care or specialized fields
As with any medication, it's important to approach their use under medical guidance to ensure safety and effectiveness
A Kaiser Family Foundation study revealed about one in eight adults in the US say theyre taking a GLP-1 drug such as Ozempic, Wegovy or Zepbound
And because this peptide combination is meant to be used consistently over weeks and months to see meaningful changes in body composition and sleep, anything that erodes nightly compliance directly undermines the results